Institut Mutualiste Montsouris
Clinical trials sponsored by Institut Mutualiste Montsouris, explained in plain language.
-
Cancer drug danger? new study probes heart risks of immunotherapy
Knowledge-focused CompletedThis study looked at how immune checkpoint inhibitors, a type of cancer drug, might harm blood vessels and speed up artery disease. Researchers followed 39 cancer patients before and after starting these drugs, using ultrasound and blood tests to track changes. The goal was to be…
Phase: NA • Sponsor: Institut Mutualiste Montsouris • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Heart alert: blood test may catch immunotherapy side effects early
Knowledge-focused CompletedThis study looked at 300 cancer patients treated with immune checkpoint inhibitors to see if measuring troponin (a heart protein) in the blood can help detect serious heart problems early. The goal was to find out if this monitoring helps prevent heart attacks, strokes, or other …
Sponsor: Institut Mutualiste Montsouris • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC